S. Im

407 total citations
17 papers, 265 citations indexed

About

S. Im is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, S. Im has authored 17 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in S. Im's work include Cancer Treatment and Pharmacology (6 papers), HER2/EGFR in Cancer Research (5 papers) and Gastric Cancer Management and Outcomes (5 papers). S. Im is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), HER2/EGFR in Cancer Research (5 papers) and Gastric Cancer Management and Outcomes (5 papers). S. Im collaborates with scholars based in South Korea, Japan and United States. S. Im's co-authors include Bhumsuk Keam, Dongwook Kim, Yung‐Jue Bang, D. S. Heo, Se‐Hoon Lee, Tae‐Yop Kim, Mee‐Ran Kim, Djin‐Ye Oh, Stefania Zambelli and Xiaoli Zhou and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

S. Im

16 papers receiving 251 citations

Peers

Countries citing papers authored by S. Im

Since Specialization

Citations

This map shows the geographic impact of S. Im's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Im with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Im more than expected).

Fields of papers citing papers by S. Im

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Im. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Im. The network helps show where S. Im may publish in the future.

Co-authorship network of co-authors of S. Im

This figure shows the co-authorship network connecting the top 25 collaborators of S. Im. A scholar is included among the top collaborators of S. Im based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Im. S. Im is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Comparative study of the refined mini-pterional approach with reduced skin incision versus the conventional mini-pterional approach for clipping unruptured middle cerebral artery aneurysms: a propensity score-matched analysis 2025 ·Neurosurgical Review ·(unknown), Si Un Lee, Yeongu Chung, (unknown), S. Im, (unknown), (unknown), Seung Pil Ban, O-Ki Kwon, Jae Seung Bang	0
2	KEYNOTE-119: Phase III study of pembrolizumab (pembro) versus single-agent chemotherapy (chemo) for metastatic triple negative breast cancer (mTNBC) 2019 ·Annals of Oncology ·Javier Cortés, Oleg Lipatov, S. Im, Anthony Gonçalvès, (unknown), Peter Schmid, Keita Tamura, Laura Testa, (unknown), (unknown), Stefania Zambelli, Nadia Harbeck, Fabrice André, R. Dent, Xiaoli Zhou, Vassiliki Karantza, (unknown), EP Winer	95
3	Ribociclib (RIB) plus tamoxifen (TAM) or a non-steroidal aromatase inhibitor (NSAI) in premenopausal women with hormone receptorpositive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): additional results from the MONALEESA-7 trial 2018 ·European Journal of Cancer ·Nadia Harbeck, Rafael Villanueva-Vázquez, Debu Tripathy, Yongjin Lu, Michelino De Laurentiis, Sherko Kümmel, D. Taylor, Aditya Bardia, SA Hurvitz, Louis T.C. Chow, S. Im, (unknown), Gareth Hughes, Michelle C. Miller, (unknown), David Chandiwana, Marco Colleoni	1
4	Actual conversion rate from total mastectomy to breast conservation after neoadjuvant chemotherapy for stages II—III breast cancer patients 2018 ·European Journal of Cancer ·Hongnan Mo, (unknown), Jinsoo Rhu, (unknown), (unknown), S. Im, (unknown), (unknown), Hyeong‐Gon Moon, Dong‐Young Noh, (unknown)	1
5	1866 First results from the double-blind placebo (PL)-controlled randomised phase III MERiDiAN trial prospectively evaluating plasma (p)VEGF-A in patients (pts) receiving first-line paclitaxel (PAC) +/- bevacizumab (BV) for HER2-negative metastatic breast cancer (mBC) 2015 ·European Journal of Cancer ·David Miles, David Cameron, Igor Bondarenko, (unknown), Juan Carlos Alcedo, R.I. Lopez, S. Im, Jean Luc Canon, (unknown), DA Yardley, (unknown), (unknown), Stanislas Hubeaux, Cheng S. Quah, Carlos Bais, J. O’Shaughnessy	7
6	A multinational, randomized phase III study of bevacizumab (Bev) with FOLFOX4 or XELOX versus FOLFOX4 alone as adjuvant treatment for colon cancer (CC): Subgroup analyses from the AVANT trial. 2011 ·Journal of Clinical Oncology ·Thierry André, Eric Van Cutsem, Hans‐Joachim Schmoll, Josep Tabernero, Stephen Clarke, Malcolm J. Moore, David Cunningham, Thomas H. Cartwright, J. Randolph Hecht, Fernando Rivera, S. Im, G. Bodoky, Ramón Salazar, F. Maindrault-Gœbel, Einat Shmueli, Emilio Bajetta, Martina Makrutzki, Aijing Shang, Armand de Gramont, (unknown)	10
7	Use of sequential FDG-PET/CT to guide extent of axillay lymph node dissection in breast cancer receiving neoadjuvant chemotherapy. 2010 ·Journal of Clinical Oncology ·Bhumsuk Keam, S. Im, (unknown), Seungyeup Han, (unknown), Keon Wook Kang, (unknown), (unknown), Do Young Noh, Y-J. Bang	1
8	Clinicopathologic characteristics of microsatellite instability (MSI) tumors in resected gastric cancer patients. 2010 ·Journal of Clinical Oncology ·(unknown), (unknown), S. Im, (unknown), (unknown), (unknown), (unknown), Haojun Yang, (unknown), Y-J. Bang	1
9	Lapatinib can restore capecitabine sensitivity in HER2-positive breast cancer. 2009 ·Cancer Research ·Yongjun Cha, (unknown), S. Han, Do‐Youn Oh, (unknown), S. Im, (unknown), (unknown)	2
10	Aggressiveness of Cancer-Care near the End-of-Life in Korea 2008 ·Japanese Journal of Clinical Oncology ·Bhumsuk Keam, Djin‐Ye Oh, Se‐Hoon Lee, Dongwook Kim, Mee‐Ran Kim, S. Im, Tae‐Yop Kim, Yung‐Jue Bang, D. S. Heo	85
11	Irinotecan Combined with 5-Fluorouracil and Leucovorin as Second-line Chemotherapy for Metastatic or Relapsed Gastric Cancer 2008 ·Japanese Journal of Clinical Oncology ·Min‐Duk Seo, K.-W. Lee, (unknown), Hyeon Gyu Yi, (unknown), Do‐Youn Oh, Jung Hwan Kim, S. Im, T.-Y. Kim, Ji Su Lee, Y-J. Bang	26
12	Phase II study and biomarker analysis of cetuximab in combination with oxaliplatin, 5-fluorouracil, leucovorin as first-line treatment in patients with recurrent or metastatic gastric cancer 2008 ·Journal of Clinical Oncology ·Song‐Hee Han, (unknown), (unknown), Haa‐Na Song, (unknown), Do‐Youn Oh, S. Im, (unknown), (unknown), (unknown)	3
13	Chemotherapy-induced transient CEA and CA19–9 surges in patients with metastatic or recurrent gastric cancer 2008 ·Journal of Clinical Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), S. Im, (unknown), (unknown), Y-J. Bang	1
14	Magnitude of HER2 amplification as a predictive factor for HER2-overexpressing metastatic breast cancer treated with weekly paclitaxel plus trastuzumab as first-line chemotherapy 2008 ·Journal of Clinical Oncology ·Hyo S. Han, (unknown), S. Im, (unknown), (unknown), Doo‐Yi Oh, (unknown), (unknown), (unknown), Yu Jeong Bang	2
15	Adjuvant 5-FU/cisplatin (FP) chemotherapy in curatively resected stage IIIA-IV M0 gastric cancer 2005 ·Journal of Clinical Oncology ·T. M. Kim, (unknown), S. Im, (unknown), (unknown), (unknown), Dae Seog Heo, Yung‐Jue Bang, (unknown), (unknown)	1
16	Efficacy of platinum-based chemotherapy after cranial irradiation in patients with brain metastasis from non-small cell lung cancer 2004 ·Journal of Clinical Oncology ·(unknown), (unknown), Tak Yun, (unknown), Dongwook Kim, S. Im, (unknown), D. S. Heo, Yung‐Jue Bang, (unknown)	1
17	Differences in embryonic development in sensitive and resistant matings to pregnancy block stimuli in mice 2003 ·Reproduction ·Hye Jin Chung, (unknown), BK Kim, Young‐Kyun Lee, S. Im, (unknown), (unknown), (unknown), (unknown), Kwan‐Sik Min, Jae‐Hoon Kim, Noboru Wakasugi, Wenjun Chang	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact